These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17124784)

  • 1. Clinical experience with recombinant pollen allergens.
    Cromwell O
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):245-6. PubMed ID: 17124784
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract]   [Full Text] [Related]  

  • 5. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant allergens for specific immunotherapy.
    Cromwell O; Häfner D; Nandy A
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering allergens.
    Mutschlechner S; Ferreira F
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):226-9. PubMed ID: 17124778
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 9. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
    Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
    Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic desensitization].
    Valovirta E
    Duodecim; 1998; 114(17):1739-46. PubMed ID: 11717782
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of recombinant allergens.
    Cromwell O; Narkus A
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):195-200; discussion 200-3. PubMed ID: 17393740
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on pollen allergens in China.
    Liu ZG; Song JJ; Kong XL
    Biomed Environ Sci; 2010 Aug; 23(4):319-22. PubMed ID: 20934121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.
    Cromwell O; Fiebig H; Suck R; Kahlert H; Nandy A; Kettner J; Narkus A
    Immunol Allergy Clin North Am; 2006 May; 26(2):261-81, vii. PubMed ID: 16701144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical use of allergenic molecules.
    Asero R
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):218-9. PubMed ID: 17124775
    [No Abstract]   [Full Text] [Related]  

  • 18. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dusting off recombinant allergens.
    Marshall GD; Davis F
    Nat Biotechnol; 1997 Aug; 15(8):718-9. PubMed ID: 9255778
    [No Abstract]   [Full Text] [Related]  

  • 20. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.